Skip to main contentAI and Advanced
/
BAYERCROP · NSEMarket ticker unavailable · configure an authorised index feed
BA
NSE · Equity shares · Chemical Manufacturing-3.00 · -0.08%
Bayer CropScience BAYERCROP
NSE:INR 3,937
BSE:INR 4,210
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for BAYERCROP
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 3,940
Day rangeINR 3,885.3 — INR 3,965.4
52-week rangeINR 3,885.3 — INR 5,489
Volume13,374
Market cap18,921.5
P/E30.29
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)5,675
Net Income (INR Cr)689.2
Rev Growth (5 Year %)5.9
EPS Growth (5 Year %)6.93
P/E Ratio30.29
Book Value625.34
EPS149.42
Price/BV6.30Computed
Research path: Interpret Bayer CropScience's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
BAYERCROPBayer CropScience1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 5,699.4 | 5,245.9 | 4,597.1 |
| Accumulated Depreciation Total | -443.5 | -384.2 | -357.9 |
| Cash Equivalents | 1,399 | 878.7 | 1,022.8 |
| Other Liabilities Total | 127.4 | 110.2 | 125.3 |
| Accrued Expenses | 2.4 | 1.9 | 0.8 |
| Common Stock Total | 44.9 | 44.9 | 44.9 |
| Other Current Assets Total | 67.4 | 54.8 | 47.1 |
| Prepaid Expenses | 8.3 | 7 | 6.8 |
| Total Assets | 5,699.4 | 5,245.9 | 4,597.1 |
| Current Portof LT Debt/Capital Leases | 43 | 43.5 | 26.1 |
| Additional Paid-In Capital | 139.4 | 139.4 | 139.4 |
| Cash | 15.6 | 6.8 | 134 |
| Total Equity | 2,965.7 | 2,850.4 | 2,849.4 |
| Long Term Investments | 24.1 | 24.6 | 25.1 |
| Retained Earnings(Accumulated Deficit) | 2,781.4 | 2,666.1 | 2,665.1 |
| Total Common Shares Outstanding | 4.49 | 4.49 | 4.49 |
| Property/Plant/Equipment Total-Gross | 849.9 | 811.6 | 740.5 |
| Tangible Book Valueper Share Common Eq | 625.34 | 603.89 | 606.11 |
| Total Liabilities | 2,733.7 | 2,395.5 | 1,747.7 |
| Total Debt | 81.8 | 105.1 | 47.1 |
| Short Term Investments | 57.4 | 35.4 | 53.9 |
| Cashand Short Term Investments | 1,472 | 920.9 | 1,210.7 |
| Total Receivables Net | 1,171.1 | 1,090.4 | 1,055.1 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Accounts Receivable-Trade Net | 1,119 | 954.2 | 962.5 |
| Property/Plant/Equipment Total-Net | 406.4 | 427.4 | 382.6 |
| Total Current Liabilities | 2,567.5 | 2,223.7 | 1,597.4 |
| Total Inventory | 2,199.5 | 2,398.5 | 1,585.8 |
| Accounts Payable | 1,237.9 | 1,098.4 | 605.1 |
| Other Currentliabilities Total | 1,284.2 | 1,079.9 | 965.4 |
| Total Long Term Debt | 38.8 | 61.6 | 21 |
| Intangibles Net | 155.3 | 136.4 | 125.4 |
| Other Long Term Assets Total | 148.4 | 143.9 | 127.6 |
| Note Receivable-Long Term | 46.9 | 42 | 30.9 |
| Total Current Assets | 4,918.3 | 4,471.6 | 3,905.5 |
| Capital Lease Obligations | 38.8 | 61.6 | 21 |
| Deferred Income Tax | Not available | 0 | 4 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %25.48
Margins
Operating Margin 12m13.74
Operating Margin 5y Avg15.61
Net Profit Margin 12m12.14
Net Profit Margin 5y13.02
Yield
Dividend Yield %3.49
Valuation
Price to Sale Ratio3.33
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskModerate risk
Board Risk24.52
Analyst consensus
ConsensusBuy
Consensus score2.38
Analyst opinions8
Strong Sell count0
Sell count0
Hold count4
Buy count3
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,749 | 2.64 L | 58.09 | — |
| Solar Industries India | INR 18,560 | 1.68 L | 99.61 | — |
| Pidilite Industries | INR 1,671 | 1.70 L | 64.76 | — |
| SRF | INR 2,626 | 77,841.16 | 44.57 | — |
| Linde India | INR 7,105 | 61,033.66 | 110.53 | — |
Shareholding
Ownership
- Promoter
- 71.43%
- FII
- 3.97%
- MF
- 9.23%
- Other
- 15.37%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Bayer CropScience Limited Submits 68th Annual Report for Financial Year 2025-26 - scanx.tradeMarket news · 21 Jul 2026, 11:58 am
Bayer CropScience Limited Submits 68th Annual Report for Financial Year 2025-26 scanx.trade
Bayer stock trades resiliently as crop science and pharmaceuticals underpin earnings - Ad-hoc-news.deMarket news · 20 Jul 2026, 11:33 am
Bayer stock trades resiliently as crop science and pharmaceuticals underpin earnings Ad-hoc-news.de
Bayer stock trades steady as investors weigh Crop Science headwinds and pharma pipeline - Ad-hoc-news.deMarket news · 19 Jul 2026, 11:30 pm
Bayer stock trades steady as investors weigh Crop Science headwinds and pharma pipeline Ad-hoc-news.de
Bayer stock trades steady as investors weigh litigation risks and crop science earnings - Ad-hoc-news.deMarket news · 19 Jul 2026, 6:32 pm
Bayer stock trades steady as investors weigh litigation risks and crop science earnings Ad-hoc-news.de
Bayer stock trades steady as crop science and pharma outlook hinge on debt reduction - ad-hoc-news.deMarket news · 17 Jul 2026, 11:47 pm
Bayer stock trades steady as crop science and pharma outlook hinge on debt reduction ad-hoc-news.de
Bayer stock trades steady as crop science and pharmaceuticals shape outlook - ad-hoc-news.deMarket news · 17 Jul 2026, 11:29 am
Bayer stock trades steady as crop science and pharmaceuticals shape outlook ad-hoc-news.de
Corporate actions
Events
- annual General MeetingAGM
- dividendRs.60.0000 per share(600%)Final Dividend
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- dividendRs.90.0000 per share(900%)Interim Dividend
- board MeetingsQuarterly Results & Interim Dividend
- annual General MeetingAGM
Rusaka Markets Community
Discussion and sentiment for Bayer CropScience
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Bayer CropScience Limited is an India-based company, which is engaged in the manufacturing, sale and distribution of insecticides, fungicides, herbicides and various other agrochemical products and corn seeds. The Company operates through the Agri Care segment. The Company’s operations include three business areas: Crop Protection, Seeds & Traits and Digital Farming. Its Crop Protection portfolio comprises a wide range of chemical and biological pest management solutions. Its Seeds & Traits develops seeds and traits that provide farmers with new solutions. Its Digital Farming consists of modern farming methods that use technology to improve crop yield and efficiency while reducing waste and environmental impact. The Company offers various brands, such as Alion Plus, Movento Energy, Solomon, Lesenta, Nativo, Permethrin, Sectin, Topstar, and others.
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- BAYERCROP
- BSE Code
- 506285
Questions
Stock FAQ
What is the symbol and ISIN of Bayer CropScience?
Bayer CropScience has the symbol BAYERCROP and ISIN - INE462A01022.
What is the current price of Bayer CropScience?
Bayer CropScience is currently trading at INR 3,937.00.
What are the year high and year low of Bayer CropScience?
Bayer CropScience has a year high of INR 5,489.00 and a year low of INR 3,885.30.
What is the market capitalization of Bayer CropScience?
Bayer CropScience has a market capitalization of INR 18,921.50 crore.
What is the P/E ratio of Bayer CropScience?
Bayer CropScience has a P/E ratio of 30.29.
What is the dividend yield of Bayer CropScience?
Bayer CropScience has a dividend yield of 3.49%.
How is the financial performance of Bayer CropScience based on revenue, net income, and EPS?
Bayer CropScience has revenue of INR 5,675.00 crore, net income of INR 689.20 crore, and EPS of INR 153.35.
What is the book value of Bayer CropScience?
Bayer CropScience has a book value of INR 625.34.
What is the debt-to-equity ratio of Bayer CropScience?
Bayer CropScience has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Bayer CropScience?
Bayer CropScience has a price-to-book ratio of 6.30 and a price-to-sales ratio of 3.33.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.